Performing Phase III Clinical Trials: Never an Easy Task

Publisher： Karger

E-ISSN： 2296-5262|25|5|402-403

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.25, Iss.5, 2002-11, pp. : 402-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What's new in stroke? Phase III randomized clinical trials of 2012–2014

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 790-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 9, 2015-08 ,pp. : 1088-1096

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials

By Jenkins Stephen G.   Fisher Alan C.   Peterson Janet A.   Nicholson Susan C.   Kaniga Koné  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3029-3036

Informa Healthcare

Access to resources Recommend Favorite

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 584-591

John Wiley & Sons Inc

Access to resources Recommend Favorite